Fiduciary Alliance LLC Has $5.01 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Fiduciary Alliance LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 260.7% in the fourth quarter, HoldingsChannel reports. The fund owned 9,893 shares of the healthcare conglomerate’s stock after purchasing an additional 7,150 shares during the quarter. Fiduciary Alliance LLC’s holdings in UnitedHealth Group were worth $5,005,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of UNH. Winthrop Advisory Group LLC boosted its stake in UnitedHealth Group by 2.4% in the fourth quarter. Winthrop Advisory Group LLC now owns 1,301 shares of the healthcare conglomerate’s stock valued at $658,000 after acquiring an additional 31 shares during the last quarter. Matrix Trust Co increased its position in UnitedHealth Group by 6.6% in the fourth quarter. Matrix Trust Co now owns 3,634 shares of the healthcare conglomerate’s stock worth $1,838,000 after buying an additional 225 shares during the last quarter. Aprio Wealth Management LLC raised its stake in UnitedHealth Group by 15.9% in the 4th quarter. Aprio Wealth Management LLC now owns 1,337 shares of the healthcare conglomerate’s stock valued at $676,000 after acquiring an additional 183 shares during the period. Czech National Bank boosted its position in UnitedHealth Group by 6.1% during the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock worth $100,937,000 after purchasing an additional 11,426 shares during the period. Finally, RMR Wealth Builders raised its holdings in UnitedHealth Group by 19.1% during the 4th quarter. RMR Wealth Builders now owns 4,034 shares of the healthcare conglomerate’s stock valued at $2,040,000 after acquiring an additional 647 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent analyst reports. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, December 9th. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Bank of America cut their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Two equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Trading Up 4.1 %

UNH traded up $21.59 during trading on Monday, hitting $542.28. 1,345,160 shares of the stock were exchanged, compared to its average volume of 3,737,545. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a 50 day simple moving average of $555.25 and a 200 day simple moving average of $562.50. The firm has a market cap of $499.05 billion, a price-to-earnings ratio of 35.33, a P/E/G ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.56 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.